Serologic response to a 23‐valent pneumococcal vaccine administered prior to autologous stem cell transplantation in patients with multiple myeloma
Abstract
Patients with multiple myeloma are known to have an increased risk of infections withStreptococcus pneumoniaeand vaccination is recommended. We retrospectively investigated the response of a 23‐valent polysaccharide‐based pneumococcal vaccine in 60 patients with multiple myeloma administered prior to autologous stem cell transplantation (ASCT). Specific antibody titers were measured before and after vaccination. Disease stage was evaluated and associated to the response. We found that 33% of the patients responded to the vaccine. There was a statistic significant association between response to the vaccine and disease stage (p = 0.01). We conclude that vaccination againstS. pneumoniaeprior toASCTis reasonable at least in patients responding well to induction therapy, but still it is important to be aware that the response is frequently poor and the duration of it is unknown.Keywords
This publication has 23 references indexed in Scilit:
- Guidelines for supportive care in multiple myeloma 2011British Journal of Haematology, 2011
- Multiple myeloma presenting with an acute bacterial infectionInternational Journal of Laboratory Hematology, 2009
- Cyclophosphamide plus dexamethasone is an efficient initial treatment before high‐dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myelomaCancer, 2007
- Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working PartyJournal of Clinical Oncology, 2005
- Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised studyBritish Journal of Haematology, 2005
- Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal PolysaccharidesClinical and Vaccine Immunology, 2003
- Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells in multiple myelomaExperimental Hematology, 2001
- Human Immunoglobulin G and Immunoglobulin G Subclasses: Biochemical, Genetic, and Clinical AspectsCritical Reviews in Clinical Laboratory Sciences, 1989
- Antibody Response to Pneumococcal Vaccination in Patients with MyelomatosisScandinavian Journal of Haematology, 1983
- Antibody Response to Pneumococcal Vaccine in Patients with Multiple MyelomaThe Journal of Infectious Diseases, 1981